202 related articles for article (PubMed ID: 37220839)
1. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
[TBL] [Abstract][Full Text] [Related]
2. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders.
Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R
Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.
Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ
J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584
[TBL] [Abstract][Full Text] [Related]
4. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
5. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
[TBL] [Abstract][Full Text] [Related]
6. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
7. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
[TBL] [Abstract][Full Text] [Related]
8. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.
Spellman S; Bray R; Rosen-Bronson S; Haagenson M; Klein J; Flesch S; Vierra-Green C; Anasetti C
Blood; 2010 Apr; 115(13):2704-8. PubMed ID: 20089963
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
10. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
[TBL] [Abstract][Full Text] [Related]
11. The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.
Lima ACM; Bonfim C; Getz J; Dornelles LN; do Amaral GB; Petterle RR; Loth G; Nabhan SK; Pereira NF; Pasquini R
HLA; 2021 Jun; 97(6):493-504. PubMed ID: 33886161
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
[TBL] [Abstract][Full Text] [Related]
13. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
Front Immunol; 2021; 12():674658. PubMed ID: 34093576
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.
Ciurea SO; Thall PF; Wang X; Wang SA; Hu Y; Cano P; Aung F; Rondon G; Molldrem JJ; Korbling M; Shpall EJ; de Lima M; Champlin RE; Fernandez-Vina M
Blood; 2011 Nov; 118(22):5957-64. PubMed ID: 21967975
[TBL] [Abstract][Full Text] [Related]
17. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis.
Ruggeri A; Rocha V; Masson E; Labopin M; Cunha R; Absi L; Boudifa A; Coeffic B; Devys A; De Matteis M; Dubois V; Hanau D; Hau F; Jollet I; Masson D; Pedron B; Perrier P; Picard C; Ramouneau-Pigot A; Volt F; Charron D; Gluckman E; Loiseau P
Haematologica; 2013 Jul; 98(7):1154-60. PubMed ID: 23242594
[TBL] [Abstract][Full Text] [Related]
18. Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation.
Zhao X; Zhao X; Huo M; Fan Q; Pei X; Wang Y; Zhang X; Xu L; Huang X; Liu K; Chang Y
J Immunol Res; 2017; 2017():1043836. PubMed ID: 28484721
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors.
Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM
Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
